Topics

. @Tocagen Axing 65% of Staff after #Cancer #Immunotherapy Combination Fails Phase III Trial: http://ow.ly/tRLy50wBXL8 pic.twitter.com/89VllmPRQN

12:25 EDT 12 Oct 2019 | Genetic Engineering News

. Axing 65% of Staff after Combination Fails Phase III Trial: http://ow.ly/tRLy50wBXL8 

Original Article: . @Tocagen Axing 65% of Staff after #Cancer #Immunotherapy Combination Fails Phase III Trial: http://ow.ly/tRLy50wBXL8 pic.twitter.com/89VllmPRQN

NEXT ARTICLE

More From BioPortfolio on ". @Tocagen Axing 65% of Staff after #Cancer #Immunotherapy Combination Fails Phase III Trial: http://ow.ly/tRLy50wBXL8 pic.twitter.com/89VllmPRQN"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...